Lidocaine Hydrochloride

盐酸利多卡因

Report date: 2026/05/16 20:00:17
NME

Base Information

Drug NameLidocaine Hydrochloride
Drug Alias Namelidocaine transdermal patch赛罗卡因Xylocaine ViscousLidopenXylocaine +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsRuptureAcute PainPain +[16] 
Global Approved IndicationsTachycardia, VentricularAnesthesia
Approved Indications in ChinaTachycardia, VentricularAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved Date1948/11/19
Country/TerritoryUnited StatesPakistanItaly +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesPAEC General HospitalLaboratoires Thea SASMartin-Luther-Universitat Halle-Wittenberg +[10] 
Inactive CompaniesLee'S Pharmaceutical LtdWake Forest University Health SciencesDentsply Pharm Lcex +[4] 
Active IndicationsRupturePainPostoperative Complications +[13] 
Inactive IndicationsAcute PainHemorrhoidsUterine Cervical Neoplasms

Other Information

ATC CodeC01BB01C05AD01D04AB01 +[7] 
Related LinksWikipediaDrugBankKEGG